Gilead Sciences (GILD) PT Raised to $110 at Piper Sandler Following a 'Very Healthy Finish To 2024'
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro raised the price target on Gilead Sciences (NASDAQ: GILD) to $110.00 (from $105.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
